Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiorenal syndrome: long road between kidney and heart
Carolina Victória Cruz Junho, Mayra Trentin‐Sonoda, Karine Panico, et al.
Heart Failure Reviews (2022) Vol. 27, Iss. 6, pp. 2137-2153
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies
Diptimayee Das, N. R. Shruthi, Antara Banerjee, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 31
Triglyceride–glucose index and prognosis in individuals afflicted with heart failure and chronic kidney disease
Chen Yang, Shaomin Li, Ke Yang, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 5, pp. 3120-3132
Open Access | Times Cited: 9
Klotho relieves inflammation and exerts a cardioprotective effect during renal ischemia/reperfusion-induced cardiorenal syndrome
Carolina Victória Cruz Junho, Laura González‐Lafuente, Raquel Silva Neres-Santos, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113515-113515
Open Access | Times Cited: 36
Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology
Carolina Victória Cruz Junho, Janina Frisch, Josefin Soppert, et al.
Clinical Kidney Journal (2023) Vol. 16, Iss. 11, pp. 1786-1803
Open Access | Times Cited: 12
A comprehensive review of acute cardio-renal syndrome: need for novel biomarkers
Abhi Dutta, Shubham Saha, Ajay Bahl, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Effect of N-Acetylcysteine in Mitochondrial Function, Redox Signaling, and Sirtuin 3 Levels in the Heart During Cardiorenal Syndrome Type 4 Development
Isabel Amador‐Martínez, Omar Emiliano Aparicio‐Trejo, Ana Karina Aranda‐Rivera, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 367-367
Open Access
Assessment and management of heart failure in patients with chronic kidney disease
Andrea Igoren Guaricci, Francesca Sturdà, Roberto Russo, et al.
Heart Failure Reviews (2023) Vol. 29, Iss. 2, pp. 379-394
Open Access | Times Cited: 9
From Cardiorenal Syndrome to Chronic Cardiovascular and Kidney Disorder
Carmine Zoccali, Francesca Mallamaci, Jean‐Michel Halimi, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 19, Iss. 6, pp. 813-820
Closed Access | Times Cited: 9
Gualou xiebai decoction ameliorates cardiorenal syndrome type II by regulation of PI3K/AKT/NF-κB signalling pathway
Ying-yu Wang, Yangyang Liu, Jie Li, et al.
Phytomedicine (2023) Vol. 123, pp. 155172-155172
Closed Access | Times Cited: 9
Differences in the Profile of Circulating Immune Cell Subsets in Males with Type 2 Cardiorenal Syndrome versus CKD Patients without Established Cardiovascular Disease
Αnila Duni, Αθανάσιος Κίτσος, Aris Bechlioulis, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1029-1029
Open Access | Times Cited: 6
Kidneys in heart failure: Impact of flozins
Tomasz Stompór, Agata Winiarska
Kardiologia Polska (2023) Vol. 81, Iss. 11, pp. 1071-1080
Open Access | Times Cited: 6
Mitochondrial Impairment: A Link for Inflammatory Responses Activation in the Cardiorenal Syndrome Type 4
Isabel Amador‐Martínez, Omar Emiliano Aparicio‐Trejo, Bismarck Bernabe-Yepes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15875-15875
Open Access | Times Cited: 5
Oxidative Stress in Beta-thalassemia Patients: Role of Enzymatic and Non-enzymatic Modulators
Tehseen Fatima, Sadaf Khan, Muhammad Khan, et al.
Protein and Peptide Letters (2023) Vol. 30, Iss. 12, pp. 1030-1037
Closed Access | Times Cited: 4
Biomarker for cardiorenal syndrome risk in patients with liver cirrhosis and type 2 diabetes in Saudi Arabia
Walaa Mohammedsaeed, Zain Alghamdi
Saudi Medical Journal (2024) Vol. 45, Iss. 7, pp. 675-684
Open Access | Times Cited: 1
Cardiovascular Alterations and Structural Changes in the Setting of Chronic Kidney Disease: a Review of Cardiorenal Syndrome Type 4
Andrei Minciunescu, Leonard Genovese, Christopher R. deFilippi
SN Comprehensive Clinical Medicine (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 7
Association between the risk of heart failure hospitalization and end-stage renal disease with digoxin usage in patients with cardiorenal syndrome: A population-based study
Kai‐Ting Chang, Hsuan‐Fu Kuo, Yu-Han Chang, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 3
Use of Computation Ecosystems to Analyze the Kidney-Heart Crosstalk
Zhuojun Wu, Johannes Lohmöller, Christiane Kühl, et al.
Circulation Research (2023) Vol. 132, Iss. 8, pp. 1084-1100
Closed Access | Times Cited: 3
Impact of inhibition of the renin-angiotensin system on early cardiac and renal abnormalities in Sprague Dawley rats fed short-term high fructose plus high salt diet
Sharif Hasan Siddiqui, Rebekah Pitpitan, Boycho Boychev, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access
Advanced Detection of Abnormal ECG Patterns Using an Optimized LADTree Model with Enhanced Predictive Feature: Potential Application in CKD
Muhammad Binsawad, Bilal Khan
Algorithms (2024) Vol. 17, Iss. 9, pp. 406-406
Open Access
Evidence of clinical trials of cardiac outcomes on renal disease
Valerie Martinez Vargas, Tushar Menon, Michael Castro, et al.
Elsevier eBooks (2024), pp. 117-128
Closed Access
Pathophysiology of cardiorenal syndrome (CRS)
Tushar Menon, Valérie Martinez, Michael Castro, et al.
Elsevier eBooks (2024), pp. 105-116
Closed Access
Application of functional magnetic resonance imaging to evaluate renal structure and function in type 2 cardiorenal syndrome
Liangli Jin, Yani Zong, Yang Pan, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access
Treatment with Rasburicase in Hospitalized Patients with Cardiorenal Syndrome: Old Treatment, New Scenario
Rosa Melero, Beatriz Torroba-Sanz, Marián Goicoechea, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3329-3329
Open Access
A new animal model of cardiorenal syndrome could be established by inducing heart failure through coronary artery ligation in spontaneously hypertensive rats
Biye Zhou, Jinbao Zhao, Dong Li
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
A Tri-Component (Glomerular, Tubular, and Metabolic) Assessment of Renal Function in Acute Heart Failure
Gracjan Iwanek, Barbara Ponikowska, Husam M. Salah, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7796-7796
Open Access
Page 1 - Next Page

Scroll to top